| Seth Landon King, PA-C | |
|
165 Natchez Trace Ave, Bowling Green, KY 42103-7940 | |
| (270) 782-7800 | |
| (270) 843-0779 |
| Full Name | Seth Landon King |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 12 Years |
| Location | 165 Natchez Trace Ave, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699022582 | NPI | - | NPPES |
| 7100217580 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA1760 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greenview Regional Hospital | Bowling green, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gilbert Barbee Moore And Mcilvoy Psc | 4082511167 | 223 |
| Commonwealth Health Corporation Inc | 5496667628 | 221 |
News Archive
The female patient, reported on the December 7 issue 45 of World J Gastroenterology, presented a rare case, with symptoms consistent with hyperadrenocorticism and hypercatecholaminism, and also had a Cushingoid appearance.
A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration for patients with an aggressive form of non-Hodgkin lymphoma.
Stand Up To Cancer, the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that Jeffrey A. Sosman, M.D., a Stand Up To Cancer Melanoma Dream Team investigator, William Pao, M.D., Ph.D., a 2009 Stand Up To Cancer Innovative Research Grant recipient and colleagues identified two novel BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, according to a study recently published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Rheumatoid arthritis (RA) patients are partially protected by the influenza vaccine 6-10 months after treatment with rituximab. Researchers determined that while the flu vaccine is safe, it is ineffective for RA patients in the first 6 months following rituximab treatment.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Seth Landon King, PA-C 201 Park St, Bowling Green, KY 42101-1759 Ph: (270) 782-7800 | Seth Landon King, PA-C 165 Natchez Trace Ave, Bowling Green, KY 42103-7940 Ph: (270) 782-7800 |
News Archive
The female patient, reported on the December 7 issue 45 of World J Gastroenterology, presented a rare case, with symptoms consistent with hyperadrenocorticism and hypercatecholaminism, and also had a Cushingoid appearance.
A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration for patients with an aggressive form of non-Hodgkin lymphoma.
Stand Up To Cancer, the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that Jeffrey A. Sosman, M.D., a Stand Up To Cancer Melanoma Dream Team investigator, William Pao, M.D., Ph.D., a 2009 Stand Up To Cancer Innovative Research Grant recipient and colleagues identified two novel BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, according to a study recently published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Rheumatoid arthritis (RA) patients are partially protected by the influenza vaccine 6-10 months after treatment with rituximab. Researchers determined that while the flu vaccine is safe, it is ineffective for RA patients in the first 6 months following rituximab treatment.
› Verified 9 days ago
Brianna Grider, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1065 Ashley St, Suite 200, Bowling Green, KY 42103 Phone: 270-843-3376 Fax: 270-780-0496 | |
Mr. Troy Dell Hyman, CST/CFA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1725 Ashley Cir, Suite 211, Bowling Green, KY 42104 Phone: 270-782-0434 Fax: 270-782-0564 | |
Kathryn M. Lewis, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 427 Us 31w Byp Ste 204, Bowling Green, KY 42101 Phone: 270-721-7166 Fax: 270-796-6860 | |
Carly R. Beckner, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1225 Fairway St, Bowling Green, KY 42103 Phone: 270-781-3910 Fax: 270-842-7177 | |
Joseph Daniel Cecil, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1065 Ashley St Ste 200, Bowling Green, KY 42103 Phone: 270-843-3376 | |
Brooke Adkins, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 250 Park St, Bowling Green, KY 42101 Phone: 270-745-1000 | |
Brandy L Pile, KCSA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 250 Park St, Bowling Green, KY 42101 Phone: 270-781-4828 Fax: 270-781-4828 |